|
1
|
SV Health Investors
Boston,
Massachusetts
|
$16.6M
|
–
|
–
|
–
|
|
|
2
|
Citadel Advisors
Miami,
Florida
|
$15.7M
|
+$14.6K
|
+145
|
+0.1%
|
|
|
3
|
Samsara BioCapital
Palo Alto,
California
|
$10.2M
|
–
|
–
|
–
|
|
|
4
|
VV Manager
Boston,
Massachusetts
|
$9.05M
|
–
|
–
|
–
|
|
|
5
|
|
$5.85M
|
+$1.01M
|
+9,987
|
+18%
|
|
|
6
|
Tekla Capital Management
Boston,
Massachusetts
|
$5.83M
|
–
|
–
|
–
|
|
|
7
|
Camber Capital Management
Boston,
Massachusetts
|
$5.45M
|
–
|
–
|
–
|
|
|
8
|
Eventide Asset Management
Boston,
Massachusetts
|
$4.77M
|
-$7.27M
|
-71,990
|
-58%
|
|
|
9
|
Sphera Funds Management
Tel Aviv,
Israel
|
$3.84M
|
-$235K
|
-2,330
|
-5%
|
|
|
10
|
BVF Inc
San Francisco,
California
|
$3.13M
|
+$3.48M
|
+34,420
|
New
|
|
|
11
|
Vanguard Group
Malvern,
Pennsylvania
|
$2.94M
|
+$1.29M
|
+12,805
|
+66%
|
|
|
12
|
Driehaus Capital Management
Chicago,
Illinois
|
$2.54M
|
+$57.3K
|
+567
|
+2%
|
|
|
13
|
Fidelity Investments
Boston,
Massachusetts
|
$2.02M
|
-$555K
|
-5,497
|
-20%
|
|
|
14
|
State Street
Boston,
Massachusetts
|
$1.42M
|
+$72.5K
|
+718
|
+5%
|
|
|
15
|
Jennison Associates
New York
|
$1.31M
|
-$147K
|
-1,456
|
-9%
|
|
|
16
|
International Biotechnology Trust
London,
United Kingdom
|
$1.26M
|
-$58.8K
|
-582
|
-4%
|
|
|
17
|
Northern Trust
Chicago,
Illinois
|
$1.1M
|
+$420K
|
+4,164
|
+52%
|
|
|
18
|
|
$896K
|
+$35.3K
|
+350
|
+4%
|
|
|
19
|
Geode Capital Management
Boston,
Massachusetts
|
$839K
|
+$5.96K
|
+59
|
+0.6%
|
|
|
20
|
Pentwater Capital Management
Naples,
Florida
|
$810K
|
-$110K
|
-1,092
|
-11%
|
|
|
21
|
Bridgeway Capital Management
Houston,
Texas
|
$444K
|
–
|
–
|
–
|
|
|
22
|
Oxford Asset Management
Oxford,
United Kingdom
|
$415K
|
+$216K
|
+2,144
|
+89%
|
|
|
23
|
DAFNA Capital Management
Los Angeles,
California
|
$364K
|
+$85.9K
|
+851
|
+27%
|
|
|
24
|
Creative Planning
Overland Park,
Kansas
|
$286K
|
–
|
–
|
–
|
|
|
25
|
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$280K
|
-$127K
|
-1,258
|
-29%
|
|
